Pennant Investors »

Compass Therapeutics shares owned by Pennant Investors

Quarter-by-quarter ownership of Compass Therapeutics (CMPX) shares owned by Pennant Investors from 13F filings

Historical chart of Pennant Investors investment in Compass Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Compass Therapeutics held by Pennant Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Compass Therapeutics by Pennant Investors

Quarter filed Position value Share count Share price at filing
2024-03-31 $394k 199k 1.98

More positions owned by Pennant Investors

Amazon (AMZN)
TransDigm Group Incorporated (TDG)
Antero Res Call Option (AR)
Microsoft Corporation (MSFT)
Micron Technology (MU)
Echostar Corp Cl A (SATS)
Alphabet Cap Stk Cl A (GOOGL)
Apple Put Option (AAPL)
Colfax Corp (ENOV)
ODP Corp. (ODP)
Perimeter Solutions Sa Common Stock (PRM)
Fibrogen (FGEN)
Arcutis Biotherapeutics (ARQT)
Altimmune Com New (ALT)
Fate Therapeutics (FATE)

View all positions for Pennant Investors

Top funds holding Compass Therapeutics

OrbiMed Advisors
Adage Capital Partners GP
Henderson Group
Blackstone Group
BlackRock
Cormorant Asset Management
Rock Springs Capital Management
FMR
Vanguard Group
Vivo Capital
Opaleye Management
Blue Owl Capital Holdings
Geode Capital Management
MPM Oncology Impact Management
Baker Bros. Advisors

View all funds holding Compass Therapeutics